![Andreas Moraitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Moraitis
Teknisk/Vetenskaplig/F&U Direktör på
MBX BIOSCIENCES, INC.
Profil
Dr. Andreas Moraitis, MD, is a Senior Vice President-Clinical Development at MBX Biosciences, Inc. Dr. Moraitis was previously employed as a Head-Clinical Development by Corcept Therapeutics, Inc. He received his doctorate degree from National & Kapodistrian University of Athens.
Aktiva positioner av Andreas Moraitis
| Företag | Position | Start |
|---|---|---|
| MBX BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-06-23 |
Tidigare kända positioner av Andreas Moraitis
| Företag | Position | Slut |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Företagsledare/Principal | - |
Andreas Moraitiss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
